Photo: HKEX Chief Executive Officer Nicolas Aguzin (seated, right) and HKSTP Chief Executive Officer Albert Wong (seated, left) shake hands after the signing of the MOU. The signing was witnessed by HKEX and HKSTP senior executives
Caproasia.com | The leading source of data, research, information & resource for financial professionals, institutional investors, professional investors and private investors (UHNWs, & HNWs). Covering capital markets, investments and private wealth in Asia. How do you invest $3 million to $300 million? How do you manage $20 million to $3 billion of assets?

This site is for accredited investors, professional investors, investment managers and financial professionals only. You should have assets around $3 million to $300 million or managing $20 million to $3 billion.





Hong Kong Exchange Explores New Biotech Initiatives, 2nd Largest Biotech Fundraising Hub with 73 IPOs Raising $29.2 Billion

9th September 2021 | Hong Kong

Hong Kong Exchange (HKEX) has signed a a Memorandum of Understanding (MOU) with Hong Kong Science and Technology Parks Corporation (HKSTP) to explore new biotech and fintech initiatives.  Hong Kong Exchange (HKEX) will gain access to HKSTP’s deep pool of biotech industry experts to assist in its review of biotech listing applications, helping to maintain HKEX’s robust standards of investor protection and leadership as the world’s number 2 biotech funding hub.  In 2019, Hong Kong Exchange (HKEX) had allowed the the listings of pre-revenue biotech issuer, helping Hong Kong to become the world’s second-largest biotech fundraising hub with 73 healthcare and biotech IPOs that had raised $29.2 billion (HKD 227 billion).  As of August 2021, over 50 healthcare companies had submitted listing applications to Hong Kong Exchange (HKEX). (IPO ~ Initial Public Offering)

“ Hong Kong Exchange Explores New Biotech Initiatives, World’s 2nd Largest Biotech Fundraising Hub with 73 IPOs Raising $29.2 Billion “

 


Hong Kong Science and Technology Parks Corporation (HKSTP) has created a unique biomedical technology development platform combining world-class infrastructure and incubation programmes, supporting companies with funding, research and development, product development and commercialisation. HKSTP now supports over 150 biotech companies covering medical devices, diagnostics, therapeutics and personal care, as well as regenerative and traditional Chinese medicine, representing a full spectrum of tech-driven healthcare solutions.

 

HKEX Chief Executive Officer Nicolas Aguzin Headshot
HKEX Chief Executive Officer, Nicolas Aguzin
HKEX Chief Executive Officer, Nicolas Aguzin:

“We are delighted to be teaming up with HKSTP, a uniquely Hong Kong institution known for its innovation and expertise, to help drive the continued development of the city’s fast-growing biotech and new economy ecosystem.

We look forward to working together, collaborating to realise our shared commitment to the community, which is to help support the growth aspirations of the leading companies of tomorrow.”

 

HKSTP Chief Executive Officer, Albert Wong:

“HKSTP firmly believes biomedical technology and fintech to be core pillars for Hong Kong’s innovation-driven future and this exciting partnership with HKEX brings us even closer to realizing this vision. This partnership creates the ideal investment platform and innovation ecosystem for the best local and international ventures to succeed and elevate Hong Kong’s position as a global biotech and fintech leader.”

 

Hong Kong:

More:

 


Hong Kong Exchange Clearing LogoAbout HKEX

Hong Kong Exchanges and Clearing Limited (HKEX) is one of the world’s major exchange groups, and operates a range of equity, commodity, fixed income and currency markets.  HKEX is the world’s leading IPO market and as Hong Kong’s only securities and derivatives exchange and sole operator of its clearing houses, it is uniquely placed to offer regional and international investors access to Asia’s most vibrant markets.

HKEX is also the global leader in metals trading, through its wholly owned subsidiaries, The London Metal Exchange (LME) and LME Clear Limited.  This commodity franchise was further enhanced with the launch of Qianhai Mercantile Exchange (QME), in China, in 2018.

HKEX launched the pioneering Shanghai-Hong Kong Stock Connect programme in 2014, further expanded with the launch of Shenzhen Connect in 2016, and the launch of Bond Connect in 2017.

Visit: www.hkexgroup.com

 



Caproasia.com | The leading financial website for financial professionals, professional investors and HNW investors. Covering capital markets, investments and private wealth in Asia. How do you invest $3 million to $300 million? How do you manage $20 million to $3 billion of assets? Quicklinks: Caproasia Access | TFC | Caproasia | Jobs

Join 14,000+ leading financial professionals and professional investors in Asia. Stay ahead of your peers & competition.
For press release, email to press@caproasia.com
For editorial, media kit, listing on TFC, events, seminars or research & data services, email to mail@caproasia.com


Previous articleCiti Private Bank: Investment Implications of the Federal Reserve Policy
Next articleSingapore MAS Setup Sustainability Group, Appoints Dr Darian McBain as Chief Sustainability Officer
Caproasia.com covering capital markets, investments and private wealth in Asia. Our users manage, advise & invest $25 trillion assets in Asia